Related Experiment Video
Updated: Feb 22, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Disorders of Sleep and Ventilatory Control in Prader-Willi Syndrome
Emily S Gillett1, Iris A Perez2
1Division of Pediatric Pulmonology and Sleep Medicine, Children's Hospital Los Angeles, 4650 Sunset Blvd, Mailstop #83, Los Angeles, CA 90027, USA. egillett@chla.usc.edu.
Insights
Prader-Willi syndrome (PWS) involves genetic defects causing breathing problems and sleep apnea. Management includes addressing obesity, using CPAP, and considering growth hormone therapy for better health outcomes.
Area of Science:
- Genetics
- Pulmonology
- Endocrinology
Background:
- Prader-Willi syndrome (PWS) is a genetic disorder affecting chromosome 15q11.2-q13, leading to distinct clinical features.
- Individuals with PWS exhibit impaired ventilatory control, craniofacial abnormalities, hypotonia, and hypothalamic dysfunction, predisposing them to sleep disordered breathing.
- The PWS phenotype progresses from infantile failure to thrive to childhood hyperphagia and obesity, with evolving sleep disordered breathing patterns.
Purpose of the Study:
- To detail the characteristic ventilatory control deficits, sleep disordered breathing (SDB), and excessive daytime sleepiness (EDS) in Prader-Willi syndrome.
- To review respiratory issues contributing to sudden death events in PWS patients.
- To discuss therapeutic strategies for SDB and growth hormone therapy in PWS.
Main Methods:
- Review of literature on ventilatory control, SDB, and EDS in PWS.
- Analysis of clinical phenotypes and progression of SDB in PWS patients.
- Discussion of treatment options including adenotonsillectomy, weight management, CPAP, and growth hormone therapy.
Main Results:
- PWS patients present with significant ventilatory control impairments and SDB, evolving from central sleep apnea in infants to obstructive sleep apnea (OSA) in older children.
- Behavioral issues and EDS are common, complicating OSA management with CPAP, even post-adenotonsillectomy.
- Respiratory compromise in PWS can increase the risk of sudden death.
Conclusions:
- Sleep disordered breathing is a critical and evolving issue in Prader-Willi syndrome, necessitating comprehensive management.
- Therapeutic interventions such as adenotonsillectomy, weight loss, CPAP, and potentially growth hormone therapy are crucial for improving respiratory and overall health outcomes.
- Addressing SDB and related complications is vital for mitigating risks and improving quality of life in individuals with PWS.
Abstract:
Prader-Willi syndrome (PWS) is an imprinted genetic disorder conferred by loss of paternal gene expression from chromosome 15q11.2-q13. Individuals with PWS have impairments in ventilatory control and are predisposed toward sleep disordered breathing due to a combination of characteristic craniofacial features, obesity, hypotonia, and hypothalamic dysfunction. Children with PWS progress from failure to thrive during infancy to hyperphagia and morbid obesity during later childhood and onward. Similarly, the phenotype of sleep disordered breathing in PWS patients also evolves over time from predominantly central sleep apnea in infants to obstructive sleep apnea (OSA) in older children. Behavioral difficulties are common and may make establishing effective therapy with continuous positive airway pressure (CPAP) more challenging when OSA persists after adenotonsillectomy. Excessive daytime sleepiness (EDS) is also common in patients with PWS and may continue after OSA is effectively treated. We describe here the characteristic ventilatory control deficits, sleep disordered breathing, and excessive daytime sleepiness seen in individuals with PWS. We review respiratory issues that may contribute to sudden death events in PWS patients during sleep and wakefulness. We also discuss therapeutic options for treating sleep disordered breathing including adenotonsillectomy, weight loss, and CPAP. Lastly, we discuss the benefits and safety considerations related to growth hormone therapy.
Related Concept Videos
Alterations in Respiration II
In Biot's breathing, the respiratory rate and depth are irregular, alternating between periods of deep gasping and apnea. Common causes...
Sleep Apnea
The condition is more prevalent among...
Other Pulmonary Disorders
REM Sleep Behavior Disorder
RBD is significantly associated with...
Hyperpnea and Hyperventilation
Physiology of Respiration II: Neurogenic Control of Respiration
Central Control
The brainstem is the primary site of central control, hosting respiratory centers:

